日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Distinct Molecular and Prognostic Profiles of Left- and Right-Sided Colorectal Cancer Revealed by NGS Analysis: The Role of SMAD4 and SETD2 Mutations

NGS分析揭示左侧和右侧结直肠癌不同的分子和预后特征:SMAD4和SETD2突变的作用

Zhao, Wenlei; Qiu, Yuxuan; Bai, Na; He, Chunhong; Yin, Jiani C; Xu, Qianru; Jian, Kaiyu; Jia, Baolei; Jiang, Lin; Liang, Feng

Predictive Effectiveness of Circulating Tumor DNA in Recurrent Early-Stage Non-Small Cell Lung Cancer: An Updated Meta-Analysis

循环肿瘤DNA在复发性早期非小细胞肺癌中的预测价值:一项更新的荟萃分析

Lu, Di; Lin, Nengke; Li, Shaobin; Jing, Qifan; Yin, Jiani C; Shi, Lina; Zhang, Zilong; Chen, Zhiming; Wang, Zhizhi; Tong, Yu; Zhai, Jianxue; Feng, Siyang; Cai, Kaican

Identification of clinicopathological-specific driver gene and genetic subtyping of colorectal cancer

结直肠癌临床病理特异性驱动基因的鉴定及基因分型

Li, Jianjiong; Wang, Chunnian; Yang, Changshun; Bao, Hua; Li, Ningyou; Huang, Xianqiang; Gong, Wei; Hong, Xinyue; Yin, Jiani C; Pang, Jiaohui; Gan, Meifu; Yuan, Danping

The Oncologist, 2025, Vol, XX, Issue XX Predictive role of ARID1A and B2M mutations and the antigen presentation pathway in the efficacy of definitive chemoradiotherapy for cervical cancer.

肿瘤学家,2025 年,第 XX 卷,第 XX 期 ARID1A 和 B2M 突变以及抗原呈递途径在宫颈癌根治性放化疗疗效中的预测作用

Zhu Chenjing, Gong Zhen, Yin Ping, Huang Jian, He Dan, Zhu Biqing, Wu Yaqin, Wang Hairong, Zhang Yaru, Jing Qifan, Yin Jiani C, Li Yue, Liu Jianyao, Hu Huanhuan, Xiao Shuyue, Sun Zhihua, Xu Hanzi

Characterization of RET fusions via integrated DNA and RNA sequencing in early-stage non-small cell lung cancer: a retrospective study

利用整合DNA和RNA测序技术对早期非小细胞肺癌中的RET融合进行表征:一项回顾性研究

Ding, Ying; Chen, Gang; He, Xiao; Shi, Yuqian; He, Chunhong; Yin, Jiani C; Zhang, Zhihong

Prevalence and therapeutic response of EGFR T790I mutation in NSCLC patients with acquired resistance to EGFR-TKIs: a retrospective cohort study

EGFR T790I突变在获得性EGFR-TKI耐药的非小细胞肺癌患者中的患病率和治疗反应:一项回顾性队列研究

Shi, Jingwei; Wang, Ye; Pang, Jiaohui; Yin, Jiani C; He, Chunhong; Zhang, Zhi; Xie, Haiyan

Characterization of clinical risk factors for enhanced molecular residual disease monitoring in resected early-stage non-small cell lung cancer

对切除的早期非小细胞肺癌进行增强分子残留病灶监测的临床危险因素进行表征

Shi, Yunfei; Lei, Youming; Liu, Yinqiang; Zhao, Wei; Yang, Qingmei; Zhang, Fujun; Bian, Li; Luo, Xiaoyu; Luo, Kang; Li, Haoyu; Liu, Fanghao; Wang, Tingguang; Liu, Yong; Ma, Ya; Yin, Jiani C; Lv, Guoli; Duan, Jin

Novel Resistance Mechanisms to Second-Generation EGFR Tyrosine Kinase Inhibitor Afatinib and Associations With Genomic Features in NSCLC

非小细胞肺癌中针对第二代表皮生长因子受体酪氨酸激酶抑制剂阿法替尼的新型耐药机制及其与基因组特征的关联

Lin, Fengwu; Zhao, Miaoqing; Wu, Qiang; Wu, Wenqi; Wu, Xiaoying; Ma, Ya; Yin, Jiani C; Yang, Meng; Gao, Min

Molecular evolution of intestinal-type early gastric cancer according to Correa cascade.

根据 Correa 级联理论,肠型早期胃癌的分子演变

Li Fangyuan, Wang Yaohui, Ping Xiaochun, Yin Jiani C, Wang Fufeng, Zhang Xian, Li Xiang, Zhai Jing, Shen Lizong

Rare mutation-dominant compound EGFR-positive NSCLC is associated with enriched kinase domain-resided variants of uncertain significance and poor clinical outcomes

罕见突变为主的EGFR阳性非小细胞肺癌与富集的、意义未明的激酶结构域变异以及不良临床预后相关。

Zhao, Weixin; Song, Ailing; Xu, Yang; Wu, Qian; Liu, Cuicui; Yin, Jiani C; Ou, Qiuxiang; Wu, Xue; Shao, Yang; Zhao, Xinmin